At the news
? BULLISHIMPACT 5/10 INSIDER-BUY filed Jul 14, 2026 at 19:00 ET
RA Capital Management, L.P., a director and 10% owner of Artiva Biotherapeutics, purchased 15,100 shares at $8.97 for a total of $135K on July 10, 2026. This is a standalone conviction buy by a major insider, signaling confidence in the company's prospects at current valuation.
- RA Capital Management (Director, 10% Owner) bought 15,100 shares at $8.97 for $135K on July 10, 2026.
- Total purchase value of $135K represents approximately 0.06% of Artiva's $221M market cap.
- Recent insider activity shows 6 buys totaling $1.7M in the last 30 days, indicating sustained insider confidence.
- Analyst consensus is 92% bullish (4 Strong Buy, 7 Buy, 1 Hold).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access